Skip to content

Author

M. Alaqarbeh

4 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

QSAR Modeling, In-silico ADMET, Molecular Docking, Biological Efficacy and Retrosynthesis: Study of Potential Anti-cancer Agents with Inhibitory Effect on Liver Cancer Stem Cells

Pr3 has a higher effectiveness in treating liver cancer when compared to the other compounds, emerges as a promising hit candidate for further experimental investigation and Lipinski characteristics and synthetic accessibility coefficient suggest their potential for therapeutic use.

Y. Moukhliss, Y. Koubi, L. Naanaai et al. · 0 citations
Open access Aug 2026

In Silico Evaluation of Selective HDAC6 Inhibitors J27820 and J22352 Against Zika Virus Proteins: Molecular Docking and Dynamics Insights

The results of this study highlight the significant advantages of J27820 and J22352, emphasizing their potential for targeted inhibition and promising opportunities for developing effective antiviral therapies against the Zika virus.

Farid Elbamtari, Etibaria Belghalia, Mhamed Elbouhi et al. · 0 citations
Open access Jul 2026

An integrative computational strategy for antidiabetic drug discovery: From QSAR modeling to retrosynthesis

A comprehensive computational approach was used to identify novel ligands with potent inhibitory activity against various indenoquinoxaline-phenylacrylohydrazide hybrids, highlighting a promising lead compound for further in vitro and in vivo investigations targeting α-amylase inhibition.

L. Naanaai, M. Alaqarbeh, A. El Aissouq et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.